Published in Pharmacotherapy on November 01, 2007
Diabetic neuropathy: mechanisms to management. Pharmacol Ther (2008) 2.57
5-HT(1A) receptor function in major depressive disorder. Prog Neurobiol (2009) 1.99
Pain and inflammatory bowel disease. Inflamm Bowel Dis (2009) 1.39
Effects of pain- and analgesia-related manipulations on intracranial self-stimulation in rats: further studies on pain-depressed behavior. Pain (2009) 1.32
Effects of kappa opioids in an assay of pain-depressed intracranial self-stimulation in rats. Psychopharmacology (Berl) (2010) 1.14
Using molecular similarity to highlight the challenges of routine immunoassay-based drug of abuse/toxicology screening in emergency medicine. BMC Emerg Med (2009) 1.12
Therapeutic potential of inhibitors of endocannabinoid degradation for the treatment of stress-related hyperalgesia in an animal model of chronic pain. Neuropsychopharmacology (2014) 1.02
Treatment-resistant depression: therapeutic trends, challenges, and future directions. Patient Prefer Adherence (2012) 1.01
Gastroparesis: concepts, controversies, and challenges. Scientifica (Cairo) (2012) 0.95
Pain, pain, go away: antidepressants and pain management. Psychiatry (Edgmont) (2008) 0.90
Targeting voltage-gated calcium channels: developments in peptide and small-molecule inhibitors for the treatment of neuropathic pain. Br J Pharmacol (2012) 0.89
Visceral analgesics: drugs with a great potential in functional disorders? Curr Opin Pharmacol (2008) 0.85
Prevalence and treatment of depression in children and adolescents with sickle cell disease: a retrospective cohort study. Prim Care Companion CNS Disord (2011) 0.85
Early reduction in painful physical symptoms is associated with improvements in long-term depression outcomes in patients treated with duloxetine. BMC Psychiatry (2011) 0.84
Measurement of prevalence of 'major depressive syndrome' among Indian patients attending pain clinic with chronic pain using PHQ-9 scale. J Anaesthesiol Clin Pharmacol (2013) 0.82
The management of diabetic neuropathy in CKD. Am J Kidney Dis (2009) 0.79
Pain and depression: a neurobiological perspective of their relationship. Psychiatry Investig (2015) 0.79
Leukocyte Gene Expression in Patients with Medication Refractory Depression before and after Treatment with ECT or Isoflurane Anesthesia: A Pilot Study. Depress Res Treat (2014) 0.78
Mitigating the risk of opioid abuse through a balanced undergraduate pain medicine curriculum. J Pain Res (2013) 0.78
Predictors of remission in the treatment of major depressive disorder: real-world evidence from a 6-month prospective observational study. Neuropsychiatr Dis Treat (2015) 0.77
Self-system therapy for distress associated with persistent low back pain: A randomized clinical trial. Psychother Res (2015) 0.77
CLASSIFICATION OF ANXIETY DISORDERS COMORBID WITH MAJOR DEPRESSION: COMMON OR DISTINCT INFLUENCES ON RISK? Depress Anxiety (2015) 0.76
Venlafaxine for depression and glossovulvodynia: a case report. Prim Care Companion J Clin Psychiatry (2010) 0.75
Computerized progress notes for chronic pain patients receiving opioids; the Prescription Opioid Documentation System (PODS). Pain Med (2010) 0.75
Non-conventional features of peripheral serotonin signalling - the gut and beyond. Nat Rev Gastroenterol Hepatol (2017) 0.75
Effects of sertraline on executive function and quality of life in patients with advanced cancer. Med Sci Monit (2014) 0.75
5-HT modulation of pain perception in humans. Psychopharmacology (Berl) (2017) 0.75
Chemotherapy outcomes for the treatment of unresectable intrahepatic and hilar cholangiocarcinoma: a retrospective analysis. Gastrointest Cancer Res (2011) 0.92
Fatal diffuse alveolar damage associated with oxaliplatin administration. Clin Colorectal Cancer (2011) 0.80